Saluda Medical Announces First U.S. Surgical Cases Using Newly Approved CAP24™ Paddle Lead

RegulatoryapprovedCAP24™ Paddle LeadPositive

AI Analysis

Summary

Saluda Medical announced the first U.S. surgical cases using its newly approved CAP24™ Paddle Lead, a closed-loop neuromodulation device for chronic neurological conditions. The commercial deployment follows U.S. regulatory approval of the device.

Outcome Details

CAP24™ Paddle Lead received U.S. approval and first surgical cases announced

Importance:6/10

Sentiment:

0.70

medical deviceneuromodulationclosed-loopFDA approvalsurgical cases

Related Companies

$SLD

Read the original article

Published by PR Newswire Clinical Trials on July 16, 2026 1:40 PM

Read Original